II型糖尿病-话题@MedSci

#II型糖尿病#

92篇内容 | 3025人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1429721, encodeId=4e701429e21a7, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=阿斯利康的三合一药物Qtrilmet获得欧盟批准，用于II型糖尿病, objectType=article, longId=183117, objectId=d3c118311e3e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3c118311e3e, replyNumber=0, likeNumber=62, createdTime=2019-11-19, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3c118311e3e, moduleTitle=阿斯利康的三合一药物Qtrilmet获得欧盟批准，用于II型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3c118311e3e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429720, encodeId=0f811429e20d9, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=BMJ：补充多不饱和脂肪酸对II型糖尿病的预防及治疗无意义, objectType=article, longId=178114, objectId=65d21e811487, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65d21e811487, replyNumber=0, likeNumber=99, createdTime=2019-08-24, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65d21e811487, moduleTitle=BMJ：补充多不饱和脂肪酸对II型糖尿病的预防及治疗无意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65d21e811487)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429719, encodeId=b2f51429e19e4, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=NEJM：利拉鲁肽治疗青少年II型糖尿病, objectType=article, longId=177731, objectId=b9831e773147, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9831e773147, replyNumber=0, likeNumber=67, createdTime=2019-08-17, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9831e773147, moduleTitle=NEJM：利拉鲁肽治疗青少年II型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9831e773147)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429718, encodeId=fadd1429e1838, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=AZ的SGLT2抑制剂Forxiga在欧盟扩展用于II型糖尿病, objectType=article, longId=177009, objectId=bd4e1e700904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd4e1e700904, replyNumber=0, likeNumber=113, createdTime=2019-08-08, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd4e1e700904, moduleTitle=AZ的SGLT2抑制剂Forxiga在欧盟扩展用于II型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd4e1e700904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429717, encodeId=6e181429e178b, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=JAMA Intern Med：吃素与II型糖尿病风险, objectType=article, longId=176136, objectId=04361e6136a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04361e6136a1, replyNumber=0, likeNumber=59, createdTime=2019-07-26, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04361e6136a1, moduleTitle=JAMA Intern Med：吃素与II型糖尿病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04361e6136a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429716, encodeId=6c111429e16b5, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=BMJ：II型糖尿病患者摄入多不饱和脂肪酸可显著降低心血管死亡和全因死亡风险, objectType=article, longId=174904, objectId=4bf71e4904ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bf71e4904ae, replyNumber=0, likeNumber=70, createdTime=2019-07-07, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bf71e4904ae, moduleTitle=BMJ：II型糖尿病患者摄入多不饱和脂肪酸可显著降低心血管死亡和全因死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bf71e4904ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429715, encodeId=a18a1429e1553, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=BMJ：饮食因素与II型糖尿病风险, objectType=article, longId=174851, objectId=60ce1e485131, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60ce1e485131, replyNumber=0, likeNumber=68, createdTime=2019-07-06, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60ce1e485131, moduleTitle=BMJ：饮食因素与II型糖尿病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60ce1e485131)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429714, encodeId=f2f01429e14da, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=NEJM：利拉鲁肽联合二甲双胍治疗青少年II型糖尿病, objectType=article, longId=165236, objectId=4f5816523692, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f5816523692, replyNumber=0, likeNumber=76, createdTime=2019-05-02, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f5816523692, moduleTitle=NEJM：利拉鲁肽联合二甲双胍治疗青少年II型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f5816523692)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429713, encodeId=d9491429e1332, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=BMJ：类固醇5α还原酶抑制剂与II型糖尿病风险, objectType=article, longId=164749, objectId=05ed164e49a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05ed164e49a1, replyNumber=0, likeNumber=91, createdTime=2019-04-23, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05ed164e49a1, moduleTitle=BMJ：类固醇5α还原酶抑制剂与II型糖尿病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05ed164e49a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429712, encodeId=489a1429e1237, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=NEJM：Canagliflozin可降低II型糖尿病肾病患者的肾衰竭及心血管疾病风险, objectType=article, longId=164454, objectId=53be1644540a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53be1644540a, replyNumber=0, likeNumber=64, createdTime=2019-04-18, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53be1644540a, moduleTitle=NEJM：Canagliflozin可降低II型糖尿病肾病患者的肾衰竭及心血管疾病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53be1644540a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429711, encodeId=20fa1429e11cc, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=人胰高血糖素样肽-1类似物Ozempic在英国上市用于治疗II型糖尿病, objectType=article, longId=158881, objectId=95b715888182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95b715888182, replyNumber=0, likeNumber=61, createdTime=2019-01-27, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95b715888182, moduleTitle=人胰高血糖素样肽-1类似物Ozempic在英国上市用于治疗II型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95b715888182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429710, encodeId=16881429e10d4, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=J Dent Res：脂连素受体激动剂减弱II型糖尿病患者的牙周炎, objectType=article, longId=158246, objectId=f841158246d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f841158246d1, replyNumber=0, likeNumber=84, createdTime=2019-01-18, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f841158246d1, moduleTitle=J Dent Res：脂连素受体激动剂减弱II型糖尿病患者的牙周炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f841158246d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429709, encodeId=a5ca1429e0906, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=JAMA：利拉利汀不会增加II型糖尿病患者的心血管及肾脏疾病风险, objectType=article, longId=157678, objectId=df6115e678f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df6115e678f1, replyNumber=0, likeNumber=62, createdTime=2019-01-11, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df6115e678f1, moduleTitle=JAMA：利拉利汀不会增加II型糖尿病患者的心血管及肾脏疾病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df6115e678f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429708, encodeId=9a7e1429e0813, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=Lancet：SGLT2抑制剂对II型糖尿病患者心血管及肾功能的影响研究, objectType=article, longId=153311, objectId=986d15331165, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=986d15331165, replyNumber=0, likeNumber=52, createdTime=2018-11-14, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=986d15331165, moduleTitle=Lancet：SGLT2抑制剂对II型糖尿病患者心血管及肾功能的影响研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=986d15331165)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429707, encodeId=8e561429e0751, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=Lancet Diabetes Endo：牙周炎与II型糖尿病患者血糖控制, objectType=article, longId=151888, objectId=96c515188899, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96c515188899, replyNumber=0, likeNumber=55, createdTime=2018-10-27, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96c515188899, moduleTitle=Lancet Diabetes Endo：牙周炎与II型糖尿病患者血糖控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96c515188899)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429706, encodeId=6ae91429e06ff, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=III期临床试验显示：阿斯利康SCLT2抑制剂Farxiga显着降低II型糖尿病患者的心力衰竭和心血管死亡住院治疗率, objectType=article, longId=149631, objectId=33901496318e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33901496318e, replyNumber=0, likeNumber=64, createdTime=2018-09-27, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33901496318e, moduleTitle=III期临床试验显示：阿斯利康SCLT2抑制剂Farxiga显着降低II型糖尿病患者的心力衰竭和心血管死亡住院治疗率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33901496318e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429705, encodeId=af4f1429e05f6, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=NEJM：II型糖尿病人群通过正规治疗可有效降低其死亡及心血管事件风险, objectType=article, longId=146759, objectId=c69f146e59e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c69f146e59e4, replyNumber=0, likeNumber=67, createdTime=2018-08-18, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c69f146e59e4, moduleTitle=NEJM：II型糖尿病人群通过正规治疗可有效降低其死亡及心血管事件风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c69f146e59e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429704, encodeId=4ea71429e04a0, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=NEJM：戒烟短期增加II型糖尿病风险，但不会削弱戒烟对健康的长期收益, objectType=article, longId=146758, objectId=1880146e58d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1880146e58d6, replyNumber=0, likeNumber=75, createdTime=2018-08-17, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1880146e58d6, moduleTitle=NEJM：戒烟短期增加II型糖尿病风险，但不会削弱戒烟对健康的长期收益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1880146e58d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429703, encodeId=c8d51429e03c2, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=GUT：虫草多糖通过调节肠道菌群变化改善肥胖及II型糖尿病小鼠症状, objectType=article, longId=144518, objectId=a02a1445183b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a02a1445183b, replyNumber=0, likeNumber=39, createdTime=2018-07-17, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a02a1445183b, moduleTitle=GUT：虫草多糖通过调节肠道菌群变化改善肥胖及II型糖尿病小鼠症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a02a1445183b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1429702, encodeId=6de21429e0297, content=<a href='/topic/show?id=9a8d9592b0' target=_blank style='color:#2F92EE;'>#II型糖尿病#</a>, objectTitle=Lancet：GLP-1及胰高血糖素受体双重激动剂MEDI0382可改善II型糖尿病患者体重, objectType=article, longId=141602, objectId=62b1141602a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62b1141602a2, replyNumber=0, likeNumber=73, createdTime=2018-06-27, rootId=0, userName=lsj629, userId=d7914226234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62b1141602a2, moduleTitle=Lancet：GLP-1及胰高血糖素受体双重激动剂MEDI0382可改善II型糖尿病患者体重, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62b1141602a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

II型糖尿病

2020-05-29

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

阿斯利康的三合一药物Qtrilmet获得欧盟批准，用于II型糖尿病

2019-11-19

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

BMJ：补充多不饱和脂肪酸对II型糖尿病的预防及治疗无意义

2019-08-24

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

NEJM：利拉鲁肽治疗青少年II型糖尿病

2019-08-17

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

AZ的SGLT2抑制剂Forxiga在欧盟扩展用于II型糖尿病

2019-08-08

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

JAMA Intern Med：吃素与II型糖尿病风险

2019-07-26

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

BMJ：II型糖尿病患者摄入多不饱和脂肪酸可显著降低心血管死亡和全因死亡风险

2019-07-07

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

BMJ：饮食因素与II型糖尿病风险

2019-07-06

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

NEJM：利拉鲁肽联合二甲双胍治疗青少年II型糖尿病

2019-05-02

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

BMJ：类固醇5α还原酶抑制剂与II型糖尿病风险

2019-04-23

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

NEJM：Canagliflozin可降低II型糖尿病肾病患者的肾衰竭及心血管疾病风险

2019-04-18

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

人胰高血糖素样肽-1类似物Ozempic在英国上市用于治疗II型糖尿病

2019-01-27

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

J Dent Res：脂连素受体激动剂减弱II型糖尿病患者的牙周炎

2019-01-18

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

JAMA：利拉利汀不会增加II型糖尿病患者的心血管及肾脏疾病风险

2019-01-11

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

Lancet：SGLT2抑制剂对II型糖尿病患者心血管及肾功能的影响研究

2018-11-14

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

Lancet Diabetes Endo：牙周炎与II型糖尿病患者血糖控制

2018-10-27

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

III期临床试验显示：阿斯利康SCLT2抑制剂Farxiga显着降低II型糖尿病患者的心力衰竭和心血管死亡住院治疗率

2018-09-27

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

NEJM：II型糖尿病人群通过正规治疗可有效降低其死亡及心血管事件风险

2018-08-18

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

NEJM：戒烟短期增加II型糖尿病风险，但不会削弱戒烟对健康的长期收益

2018-08-17

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

GUT：虫草多糖通过调节肠道菌群变化改善肥胖及II型糖尿病小鼠症状

2018-07-17

lsj629 (审核中...)

前往app查看评论内容

#II型糖尿病#

Lancet：GLP-1及胰高血糖素受体双重激动剂MEDI0382可改善II型糖尿病患者体重

2018-06-27

科室
- - 订阅+
  - 更多科室
工具
服务